Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
This study is ongoing, but not recruiting participants.
First Posted: July 12, 2013
Last Update Posted: August 3, 2017
Eli Lilly and Company
Information provided by (Responsible Party):